Exchange: NYSE·Updated 07:59 PM EDT

BMY News

News
all
press releases
Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?
Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks
Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?
Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks
More News
AbbVie's Temab-A Gets Two FDA Breakthrough Therapy Tags in Cancer
ABBV's Temab-A wins two FDA Breakthrough Therapy designations for treating colorectal cancer and non-small cell lung cancer.
Zacks
Bristol Myers Squibb Announces ZENBEXUSTM (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates Superior Progression-Free Survival vs. Standard of Care in Relapsed and Refractory Multiple Myeloma in Phase 3...
Bristol Myers Squibb Announces ZENBEXUSTM (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates Superior Progression-Free Survival vs. Standard of Care in Relapsed and Refractory Multiple Myeloma in Phase 3 EXCALIBER-RRMM Study Bristol Myers Squibb (NYSE: BMY) today...
Business Wire
Can Reblozyl Power Bristol Myers' Top-Line Growth Going Forward?
Reblozyl's strong growth is helping Bristol Myers offset declining legacy drug sales, with new indications offering further upside.
Zacks
Can Redwire's Microgravity Pharma Work Create New Revenue Streams?
RDW expands microgravity applications into pharmaceutical research, creating potential revenue streams through research and licensing.
Zacks
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
Zacks.com featured highlights Dollar General, Bristol-Myers Squibb and Equinor ASA
Dollar General, Bristol-Myers Squibb and Equinor ASA have been highlighted in this Screen of The Week article.
Zacks
BMY or ARGX: Which Is the Better Value Stock Right Now?
BMY vs. ARGX: Which Stock Is the Better Value Option?
Zacks
Are Investors Undervaluing Bristol Myers Squibb (BMY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks
3 Stocks With Broker Rating Upgrades Amid Resilient Equity Markets
Dollar General, Bristol-Myers and Equinor stand out after broker rating upgrades, backed by projected earnings growth and resilient U.S. equity markets.
Zacks

Advertisement|Remove ads.